For intramedullary gliomas, accurately determining tumor grading and molecular marker status (such as α‐thalassemia/mental retardation syndrome X‐linked and tumor protein P53) is essential for treatment planning and prognosis. Here, TP53 is linked to alpha thalassemia spectrum.